Patent details
EP2099451 Title: COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE
Basic Information
- Publication number:
- EP2099451
- PCT Application Number:
- PCT/US/2007/024712
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078624202
- PCT Publication Number:
- WO/2008/070011
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE
- French Title of Invention:
- COMBINAISON D'UN INHIBITEUR DE HDAC ET D'UN ANTIMETABOLITE
- German Title of Invention:
- KOMBINATION EINES HDAC-HEMMERS MIT EINEM ANTIMETABOLITEN
- SPC Number:
Dates
- Filing date:
- 30/11/2007
- Grant date:
- 10/02/2016
- EP Publication Date:
- 10/02/2016
- PCT Publication Date:
- 12/06/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/09/2009
- EP B1 Publication Date:
- 10/02/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 30/11/2016
- Expiration date:
- 30/11/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/11/2007
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- ATADJA Peter Wisdom
- Address:
- United States (US)
Priority
- Priority Number:
- 868388 P
- Priority Date:
- 04/12/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/706;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|